Phase 2 proof-of-concept study of RTB101 in Parkinson's-disease
Phase of Trial: Phase II
Latest Information Update: 13 Nov 2018
At a glance
- Drugs Dactolisib (Primary)
- Indications Parkinson's disease
- Focus Proof of concept; Therapeutic Use
- 13 Nov 2018 According to a resTORbio media release, the company expects initiation of this trial by the end of the first quarter of 2019.
- 09 Aug 2018 According to a resTORbio media release, this trial is anticipated to start by the first quarter 2019.
- 05 Apr 2018 Patient gender and indication are assumed.